Chabiotech Co.,Ltd. (KOSDAQ:085660)
South Korea · Delayed Price · Currency is KRW 7,810.00
-230.00 (-2.86%)
Sep 22, 2026, 3:30 PM KST
Chabiotech Market Cap
Chabiotech has a market cap or net worth of 743.72 billion as of September 22, 2026. Its market cap has decreased by -11.31% in one year.
Market Cap
743.72B
Enterprise Value
1.81T
Revenue
1.31T
Ranking
n/a
PE Ratio
52.11
Stock Price
7,810.00
ChartMarket Cap Chart
Since February 23, 2009, Chabiotech's market cap has increased from 334.13B to 743.72B, an increase of 122.58%. That is a compound annual growth rate of 4.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 22, 2026 | 722.44B | -35.46% |
| Dec 30, 2025 | 1.12T | 74.51% |
| Dec 30, 2024 | 641.46B | -41.85% |
| Dec 28, 2023 | 1.10T | 50.82% |
| Dec 29, 2022 | 731.49B | -34.83% |
| Dec 30, 2021 | 1.12T | 6.53% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kolon TissueGene | 1.36T |
| Orum Therapeutics | 812.31B |
| Pharmicell | 751.85B |
| Komipharm International | 711.84B |
| Onconic Therapeutics | 674.76B |
| Hyundai Bioscience | 656.22B |
| GI Innovation | 616.77B |
| Medy-Tox | 434.64B |